Ana Patricia Carvalho
Overview
Explore the profile of Ana Patricia Carvalho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin F, Palladino C, Mateus R, Bolzan A, Gomes P, Brito J, et al.
PLoS One
. 2017 Jul;
12(7):e0181352.
PMID: 28715460
Background: Early diagnosis and treatment reduces HIV-1-related mortality, morbidity and size of viral reservoirs in infants infected perinatally. Commercial molecular tests enable the early diagnosis of infection in infants but...
2.
Duarte F, Miranda A, Peres S, Diogo I, Goncalves F, Carvalho A, et al.
AIDS
. 2016 Jun;
30(10):1687-8.
PMID: 27243780
No abstract available.
3.
Gomes P, Carvalho A, Diogo I, Goncalves F, Costa I, Cabanas J, et al.
J Virol Methods
. 2013 May;
193(1):18-22.
PMID: 23692686
Quantitation of HIV-1 RNA levels in plasma has significant prognostic value since high viral load concentrations in plasma are associated with a faster disease progression. Viral load testing became one...
4.
Libin P, Beheydt G, Deforche K, Imbrechts S, Ferreira F, Van Laethem K, et al.
Bioinformatics
. 2013 May;
29(11):1477-80.
PMID: 23645815
Summary: RegaDB is a free and open source data management and analysis environment for infectious diseases. RegaDB allows clinicians to store, manage and analyse patient data, including viral genetic sequences....
5.
Vercauteren J, Theys K, Carvalho A, Valadas E, Duque L, Teofilo E, et al.
J Antimicrob Chemother
. 2012 Dec;
68(4):911-4.
PMID: 23228933
Objectives: Despite a decreasing mortality and morbidity in treated HIV-1 patients, highly active antiretroviral treatment (HAART) can still fail due to the development of drug resistance. Especially, multidrug-resistant viruses pose...
6.
Palma A, Abecasis A, Vercauteren J, Carvalho A, Cabanas J, Vandamme A, et al.
Infect Genet Evol
. 2009 Jul;
10(3):373-9.
PMID: 19577015
Europe is currently observing a significant rise in non-B subtypes. Consequently, the effect of genetic variability on therapy response or genotypic resistance interpretation algorithms is an emerging concern. The purpose...
7.
Vercauteren J, Deforche K, Theys K, Debruyne M, Duque L, Peres S, et al.
Retrovirology
. 2008 Feb;
5:12.
PMID: 18241328
Despite improvements in HIV treatment, the prevalence of multidrug resistance and full class resistance is still reported to be increasing. However, to investigate whether current treatment strategies are still selecting...
8.
Abecasis A, Deforche K, Bacheler L, McKenna P, Carvalho A, Gomes P, et al.
Antivir Ther
. 2006 Sep;
11(5):581-9.
PMID: 16964826
Objective: To compare baseline susceptibility to protease inhibitors among HIV-1 isolates of subtypes C, F, G and CRF02_AG, and to identify polymorphisms that determine the differences in susceptibility. Methods: A...
9.
Gomes P, Palma A, Cabanas J, Abecasis A, Carvalho A, Ziermann R, et al.
J Virol Methods
. 2006 May;
135(2):223-8.
PMID: 16675034
Quantitation of HIV-1 RNA levels in plasma has an undisputed prognostic value and is extremely important for evaluating response to antiretroviral therapy. The purpose of this study was to evaluate...
10.
Snoeck J, Kantor R, Shafer R, Van Laethem K, Deforche K, Carvalho A, et al.
Antimicrob Agents Chemother
. 2006 Jan;
50(2):694-701.
PMID: 16436728
The major limitation of drug resistance genotyping for human immunodeficiency virus remains the interpretation of the results. We evaluated the concordance in predicting therapy response between four different interpretation algorithms...